FAAS
MRTX

First Allied Advisory Services’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

First Allied Advisory Services’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6,400
Closed -$302K – 1211
2018
Q3 		$302K Buy
+6,400
New +$302K 0.01% 903